High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.7M
$1,670,870
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Viswanadhan Krishnan
• Officer • Chief Corp Dev & Strategy
Sell to CoverΔOwn -36.5%
2026-03-05
$82,260
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Corp Dev & Strategy
Sell to CoverΔOwn -36.5%
|
2026-03-05 | $82,260 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Washburn Theodore James Jr.
• Officer • Principal Accounting Officer
Discretionary SellΔOwn -85.9%
2026-03-03
$152,255
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Principal Accounting Officer
Discretionary SellΔOwn -85.9%
|
2026-03-03 | $152,255 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Burns James William
• Officer • Chief Legal Officer
Sell to Cover
2026-03-02
$116,738x3
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Legal Officer
Sell to Cover
|
2026-03-02 | $116,738x3 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Gheuens Sarah
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$83,057x2
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $83,057x2 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $522,873x3 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2026-03-02 | $145,814x4 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Milanova Tsveta
• Officer • Chief Commercial Officer
Sell to Cover
2026-03-02
$83,057x2
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $83,057x2 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Washburn Theodore James Jr.
• Officer • Principal Accounting Officer
Sell to CoverΔOwn -11.5%
2026-03-02
$64,378x3
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Principal Accounting Officer
Sell to CoverΔOwn -11.5%
|
2026-03-02 | $64,378x3 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-11-12 | $8,768 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Gheuens Sarah
• Officer • Chief Medical Officer
10b5-1 Sell
2025-11-11
$107,436
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-11-11 | $107,436 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Gheuens Sarah
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-30
$8,762
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-30 | $8,762 | S | Form 4 |
|
AGIO
S
AGIOS PHARMACEUTICALS, INC.
Gheuens Sarah
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-27
$145,024
|
||||||
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-27 | $145,024 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-10-08 | $8,200 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
Director
10b5-1 Sell
|
2025-09-30 | $8,000 | S | Form 4 |
| AGIO |
AGIOS PHARMACEUTICALS, INC.
|
CFO
Sell to Cover
|
2025-09-26 | $134,247 | S | Form 4 |